Figure 3.
B220+Gr1–c-Kit+cells contain leukemia-initiating cells. (A) Representative flow cytometric profiles of c-Kit in the B220+Gr1–, B220+Gr1+, and B220–Gr1+ fractions of leukemic 3q21q26 (left) and 3q21q26::Gata2+/− (right) mouse bone marrows. Note that the B220+Gr1– fraction is predominant in the 3q21q26::Gata2+/− mice in right panel. (B) Percentages of c-Kit+ cells in the B220+Gr1–, B220+Gr1+, and B220–Gr1+ fractions in the bone marrow of the leukemic 3q21q26 mice (n = 35) and the B220+Gr1– fraction in the leukemic 3q21q26::Gata2+/− mice (n = 15). Parameters for the box plots are defined in the Statistical analysis paragraph of “Methods.” (C) Wright-Giemsa staining of leukemic cells in the B220+Gr1–, B220+Gr1+, and B220–Gr1+ fractions from the leukemic 3q21q26 and B220+Gr1– fraction from the leukemic 3q21q26::Gata2+/− mice (c-Kit+ [top line] and c-Kit− [bottom line]). (D) Colony-forming ability of B220+Gr1–c-Kit+, B220+Gr1+c-Kit+, B220–Gr1+c-Kit+, B220+Gr1–c-Kit–, B220+Gr1+c-Kit– and B220–Gr1+c-Kit– populations from the leukemic 3q21q26 mice (n = 6). Representative colony morphologies from the B220+Gr1–c-Kit+, B220+Gr1+c-Kit+, and B220–Gr1+c-Kit+ populations are shown in the right panels. (E) Kaplan-Meier survival curves of mice receiving B220+Gr1–c-Kit+ (n = 16; median, 56 days), B220+Gr1+c-Kit+ (n = 8; median, not determined), and B220–Gr1+c-Kit+ (n = 6; median, not determined) cells. (F) Representative flow cytometric patterns of leukemic cells in donor mice and donor-derived (CD45.1 homozygous or CD45.1/CD45.2 heterozygous) leukemic cells in recipient mice receiving B220+Gr1–c-Kit+ cells. (G) Relative expression levels of human EVI1 messenger RNA (mRNA) (left panel), total (human + mouse) EVI1 mRNA (middle panel), and mouse endogenous Gata2 mRNA (right panel) in B220+Gr1–c-Kit+ (n = 6), B220+Gr1+c-Kit+ (n = 5), B220–Gr1+c-Kit+ (n = 4), B220+Gr1–c-Kit– (n = 4), B220+Gr1+c-Kit– (n = 3), and B220–Gr1+c-Kit– (n = 3) populations. Bar graphs represent mean ± standard deviation (SD). *, P < .05; **, P < .01.